Enzon Pharmaceuticals, Inc. (ENZN)
OTCMKTS · Delayed Price · Currency is USD
0.1000
+0.0130 (14.94%)
Mar 31, 2025, 4:00 PM EST

Enzon Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
0.781.37-0.19-0.47-1.31
Upgrade
Other Operating Activities
0.34-0.16-0.2--
Upgrade
Change in Accounts Payable
---0.03-0.02
Upgrade
Change in Other Net Operating Assets
00.09-0.27-0.06-0.02
Upgrade
Operating Cash Flow
1.121.31-0.66-0.5-0.38
Upgrade
Operating Cash Flow Growth
-14.02%----
Upgrade
Issuance of Common Stock
----43.6
Upgrade
Preferred Dividends Paid
-1.28-1.28---
Upgrade
Dividends Paid
-1.28-1.28---
Upgrade
Other Financing Activities
-----0.52
Upgrade
Financing Cash Flow
-1.28-1.28--43.08
Upgrade
Net Cash Flow
-0.150.03-0.66-0.542.7
Upgrade
Levered Free Cash Flow
-0.83-0.560.36-0.33-0.37
Upgrade
Unlevered Free Cash Flow
-0.83-0.560.36-0.33-0.37
Upgrade
Change in Net Working Capital
-0-0.09-10.03-0.45
Upgrade
Updated Feb 21, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.